General Information of the Cell Line
Cell Line ID
CL000203
Cell Line Name
T24
Synonyms
T-24
T 24
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0554
Tissue Information
Urinary bladder
Disease
Bladder carcinoma (NCIt: C4912)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT00991, Histone deacetylase 1
Compound ID Compound Name Compound Formula
CP0005479
CHEBI:46024
   Show/Hide
C17H22N2O3
 1
1
EC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0041513
(E)-3-[4-(3,4-Dimethoxy-benzenesulfonylamino)-phenyl]-N-hydroxy-acrylamide
   Show/Hide
C17H18N2O6S
 1
1
EC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0103410
N-(2-aminophenyl)-4-[[[6-(2-morpholin-4-ylethoxy)-1,3-benzothiazol-2-yl]amino]methyl]benzamide
   Show/Hide
C27H29N5O3S
 1
1
EC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0103411
N-(2-aminophenyl)-4-[[(6-methoxy-1,3-benzothiazol-2-yl)amino]methyl]benzamide
   Show/Hide
C22H20N4O2S
 1
1
EC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0155651
N-(2-aminophenyl)-4-[(6-methoxy-1H-benzimidazol-2-yl)sulfanylmethyl]benzamide
   Show/Hide
C22H20N4O2S
 1
1
EC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0336829
4-((1H-benzo[d]imidazol-2-ylamino)methyl)-N-(2-aminophenyl)benzamide
   Show/Hide
C21H19N5O
 1
1
EC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0344156
N-(2-aminophenyl)-4-[[(5-chloro-1,3-benzoxazol-2-yl)amino]methyl]benzamide
   Show/Hide
C21H17ClN4O2
 1
1
EC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0050838
(E)-3-[4-(4-Chloro-benzenesulfonylamino)-phenyl]-N-hydroxy-acrylamide
   Show/Hide
C15H13ClN2O4S
 1
1
EC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0050837
(E)-N-Hydroxy-3-[4-(4-trifluoromethoxy-benzenesulfonylamino)-phenyl]-acrylamide
   Show/Hide
C16H13F3N2O5S
 1
1
EC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0195301
N-(2-aminophenyl)-4-[[(6-bromo-1,3-benzothiazol-2-yl)amino]methyl]benzamide
   Show/Hide
C21H17BrN4OS
 1
1
EC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0202163
N-(2-aminophenyl)-4-[[6-(pyridin-3-ylmethylamino)-1,3-benzothiazol-2-yl]sulfanylmethyl]benzamide
   Show/Hide
C27H23N5OS2
 1
1
EC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0155652
N-(2-aminophenyl)-4-(1,3-benzothiazol-2-ylsulfanylmethyl)benzamide
   Show/Hide
C21H17N3OS2
 1
1
EC50 = 3000 nM
   TI
   LI
   LO
   TS
CP0202162
N-(2-aminophenyl)-4-[[6-(pyridin-2-ylmethylamino)-1,3-benzothiazol-2-yl]sulfanylmethyl]benzamide
   Show/Hide
C27H23N5OS2
 1
1
EC50 = 3000 nM
   TI
   LI
   LO
   TS
CP0048624
(E)-3-(4-Benzenesulfonylamino-phenyl)-N-hydroxy-acrylamide
   Show/Hide
C15H14N2O4S
 1
1
EC50 = 5000 nM
   TI
   LI
   LO
   TS
CP0065009
(E)-N-Hydroxy-3-[4-(4-methoxy-benzenesulfonylamino)-phenyl]-acrylamide
   Show/Hide
C16H16N2O5S
 1
1
EC50 = 5000 nM
   TI
   LI
   LO
   TS
CP0095776
4-Benzenesulfonylamino-N-hydroxy-benzamide
   Show/Hide
C13H12N2O4S
 1
1
EC50 = 5000 nM
   TI
   LI
   LO
   TS
CP0141093
(E)-3-[4-(3,4-Dichloro-benzenesulfonylamino)-phenyl]-N-hydroxy-acrylamide
   Show/Hide
C15H12Cl2N2O4S
 1
1
EC50 = 5000 nM
   TI
   LI
   LO
   TS
CP0170825
(E)-3-[4-(4-tert-Butyl-benzenesulfonylamino)-phenyl]-N-hydroxy-acrylamide
   Show/Hide
C19H22N2O4S
 1
1
EC50 = 5000 nM
   TI
   LI
   LO
   TS
CP0214010
3-(4-Benzenesulfonylamino-phenyl)-N-hydroxy-propionamide
   Show/Hide
C15H16N2O4S
 1
1
EC50 = 5000 nM
   TI
   LI
   LO
   TS
CP0336828
N-(2-aminophenyl)-4-[[6-(2-morpholin-4-ylethylamino)-1,3-benzothiazol-2-yl]sulfanylmethyl]benzamide
   Show/Hide
C27H29N5O2S2
 1
1
EC50 = 5000 nM
   TI
   LI
   LO
   TS
CP0144077
(E)-N-Hydroxy-3-[4-(toluene-4-sulfonylamino)-phenyl]-acrylamide
   Show/Hide
C16H16N2O4S
 1
1
EC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0217425
(E)-N-Hydroxy-3-[4-(toluene-3-sulfonylamino)-phenyl]-acrylamide
   Show/Hide
C16H16N2O4S
 1
1
EC50 = 12000 nM
   TI
   LI
   LO
   TS
CP0192280
(E)-N-Hydroxy-3-[4-(4-nitro-benzenesulfonylamino)-phenyl]-acrylamide
   Show/Hide
C15H13N3O6S
 1
1
EC50 = 20000 nM
   TI
   LI
   LO
   TS
CP0133881
(E)-N-Hydroxy-3-[4-(3-trifluoromethyl-benzenesulfonylamino)-phenyl]-acrylamide
   Show/Hide
C16H13F3N2O4S
 1
1
EC50 = 22000 nM
   TI
   LI
   LO
   TS
CP0050840
4-(4-Benzenesulfonylamino-phenyl)-N-hydroxy-butyramide
   Show/Hide
C16H18N2O4S
 1
1
EC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0061532
3-(4-Benzenesulfonylamino-phenyl)-N-hydroxy-2-methyl-propionamide
   Show/Hide
C16H18N2O4S
 1
1
EC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0100064
(E)-N-Hydroxy-3-[4-(2,4,5-triisopropyl-benzenesulfonylamino)-phenyl]-acrylamide
   Show/Hide
C24H32N2O4S
 1
1
EC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0113283
2-(4-Benzenesulfonylamino-benzyl)-N-hydroxy-3-methyl-butyramide
   Show/Hide
C18H22N2O4S
 1
1
EC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0114427
2-(4-Benzenesulfonylamino-phenyl)-N-hydroxy-acetamide
   Show/Hide
C14H14N2O4S
 1
1
EC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0120860
(E)-3-(4-Benzenesulfonylamino-phenyl)-N-hydroxy-2-methyl-acrylamide
   Show/Hide
C16H16N2O4S
 1
1
EC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0135449
(E)-N-Hydroxy-3-[4-(4-sulfamoyl-benzenesulfonylamino)-phenyl]-acrylamide
   Show/Hide
C15H15N3O6S2
 1
1
EC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0148039
(E)-3-[4-(Benzenesulfonyl-methyl-amino)-phenyl]-N-hydroxy-acrylamide
   Show/Hide
C16H16N2O4S
 1
1
EC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0265824
(E)-3-[4-(2,4-Dichloro-benzenesulfonylamino)-phenyl]-N-hydroxy-acrylamide
   Show/Hide
C15H12Cl2N2O4S
 1
1
EC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0034824
4-((1H-benzo[d]imidazol-2-ylthio)methyl)-N-(2-aminophenyl)benzamide
   Show/Hide
C21H18N4OS
 1
1
EC50 < 1000 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0112599
US8569511, 2
   Show/Hide
C23H22F2N6O2  1
1
IC50 = 4700 nM
   TI
   LI
   LO
   TS
CP0224766
4-(methylamino)-2-[4-methyl-3-(prop-2-enoylamino)anilino]-N-[2-methyl-5-[(3,4,5-trimethoxybenzoyl)amino]phenyl]pyrimidine-5-carboxamide
   Show/Hide
C33H35N7O6  1
1
GI50 = 8980 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Urinary bladder)
Cell Line Name Organism Disease
RT-112 Homo sapiens (Human) Bladder carcinoma
ECV-304 Homo sapiens (Human) Bladder carcinoma
UM-UC-3 Homo sapiens (Human) Bladder carcinoma
RT-4 Homo sapiens (Human) Bladder carcinoma
RT112/84-FABP4 Homo sapiens (Human) Bladder carcinoma